Latest News

Canada Invests $19 Million in TMU-Led Talent Development Program to Strengthen Biomanufacturing Sector

In a bid to fortify Canada's healthcare workforce and enhance its capacity to tackle forthcoming health challenges, Toronto Metropolitan University (TMU) has secured $19 million in federal funding for an immersive talent development program. Spearheaded by TMU Faculty of Science professor Darius Rackus, the initiative, named the Biomanufacturing Hub Network (BioHubNet), is set to revolutionize Canada's biomanufacturing sector. Joining forces with directors Molly Shoichet and Gilbert Walker, both esteemed professors at the University of Toronto, Professor Rackus is poised to steer BioHubNet toward its ambitious goals. Backed by the Canada Biomedical Research Fund (CBRF), this initiative is designed to bolster Canada's ability to produce vital vaccines and therapeutics, addressing critical

ONO Pharmaceutical to Acquire Deciphera Pharmaceuticals in $2.4 Billion Merger

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a prominent biopharmaceutical entity with a focus on pioneering medicines for cancer treatment, has announced its forthcoming acquisition by ONO Pharmaceutical Co., Ltd. (ONO) in a definitive merger agreement. The acquisition, valued at $2.4 billion, will be executed

Cyberattack on UnitedHealth Group's Change Healthcare Unit Sparks Congressional Concerns

UnitedHealth Group's financial outlook for the year has been marred by a cyberattack on its subsidiary, Change Healthcare, with the company estimating more than $1 billion in costs stemming from the breach. The attack, which occurred on February 21st, targeted Change Healthcare, the largest clearinghouse for medical insurance payments in the U.S., resulting in significant disruptions across the healthcare sector. During a congressional hearing, U.S. lawmakers scrutinized the cyberattack's implications, particularly questioning the concentration of power among a few healthcare giants and its potential exacerbation of cyber risks. UnitedHealth's president and CFO, John Rex, outlined the direct costs of the attack, including expenses for system restoration and medical costs linked to

New Therapeutic Device Offers Hope in the Fight Against Pediatric Sepsis

In the ongoing battle against sepsis, a life-threatening condition triggered by a dysregulated response to infection, a breakthrough therapeutic device has emerged to offer a ray of hope, particularly for pediatric patients. Developed at the University of Michigan in collaboration with SeaStar Medical, the selective

Tailored Physical Therapy Program Shows Significant Improvements in Axial Spondyloarthritis Patients

A recent study published in the journal Therapeutic Advances in Musculoskeletal Disease has demonstrated the efficacy of a two-week tailored physical therapy program in significantly improving spinal mobility and function among individuals with axial spondyloarthritis (axSpA). Led by a research team at Ruhr-University Bochum in Germany, the study utilized a novel electronic device called Epionics SPINE (ES) to objectively evaluate spinal mobility, providing valuable clinical evidence for the effectiveness of exercise-based interventions in managing axSpA. Axial spondyloarthritis is a chronic arthritis primarily affecting the joints in the spine, pelvis, and chest. It encompasses both nonradiographic axSpA (nr-axSpA), where no visible damage is observed on X-rays, and radiographic axSpA

Revolutionizing Stroke Rehabilitation: The Promise of Telerehabilitation

In the aftermath of a stroke, individuals often confront formidable challenges, particularly in the restoration of lower body mobility and the pursuit of regained independence. These obstacles not only encompass physical limitations but also extend to mental well-being and overall quality of life. Recognizing this
Medical Equipment

HORIBA Medical Launches Next Neneration HELO Fully Automated Modular Hematology Solution

Montpellier, France (4 January 2024) – HORIBA Medical has launched the new HELO 2.0 high throughput automated hematology platform which is CE-IVDR approved. Following the success of HORIBA Medical’s previous HELO, this new generation high-end hematology range has been designed in consultation with customers to further improve and cover all needs of high throughput fully automated hematology. HELO 2.0 offers a highly flexible and efficient modular hematology solution that is fully scalable with many possible configurations for mid to large-scale laboratories. HORIBA Medical’s advanced technologies embedded in the platform’s Yumizen H2500 and Yumizen H1500 hematology analyzers ensure high quality analytical performance. This includes 360-degree sample mixing without any premixing required.

Pulmonary embolism startup Flow Medical raises $2M in friends-and-family round

Flow Medical has recently secured $2 million in a funding round primarily from friends and family. The Chicago-based company is actively engaged in the development of an innovative thrombolysis catheter designed to address acute pulmonary embolism (PE). The secured funds will be directed towards research and

Olympus Announces Launch of Next Generation Electrosurgical Generator

Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced market availability of its newest electrosurgical generator for use in the treatment of bladder cancer and enlarged prostate. The ESG-410 Electrosurgical Generator supports options
Product Focus

Stryker Announces Prophecy Footprint as Part of its Prophecy Surgical Planning Platform

Stryker, a prominent name in medical technology, has introduced Prophecy Footprint, a new addition to its Prophecy Surgical Planning platform, designed to cater specifically to foot and ankle surgeries, including complex procedures like total ankle replacement. This development marks a significant advancement in addressing the challenges often encountered in traditional surgical planning methods. Traditional surgical planning tends to focus narrowly on the targeted joint, often overlooking potential issues in surrounding areas. However, with approximately 70% of patients requiring additional procedures during total ankle replacement, a more comprehensive approach becomes imperative. Prophecy Footprint seeks to bridge this gap by offering a more holistic perspective on surgical planning.

FDA clears next-generation cardiovascular, thoracic CT scanners

Arineta Cardio Imaging has recently announced a significant milestone with the FDA 510(k) clearance and the subsequent launch of its advanced cardiovascular CT scanners. The cutting-edge system, named SpotLight, has been meticulously crafted to cater specifically to cardiovascular CT imaging needs. What sets this

Laser-assisted robotic knee surgery advances orthopaedic treatment

Robotic-assisted knee replacement surgery with laser technology is garnering attention as a groundbreaking advancement in orthopaedic care. With its array of benefits for patients and surgeons alike, this cutting-edge approach is transforming the landscape of knee surgeries. In an interview, Dr. Anush Rao, Specialist

Breakthroughs in Antiviral Drug Development: New Hope for Influenza and Dengue Patients

In the ongoing battle against viral infections such as influenza and dengue fever, recent advancements in antiviral drug development offer promising prospects for treatment and prevention. A collaborative effort between researchers from St. Jude Children’s Research Hospital, University of Houston, Tufts University School of Medicine, and Fox Chase Cancer Center has resulted in the creation of a groundbreaking drug capable of preventing flu-induced lung injury. This development, published in the prestigious journal Nature, marks a significant milestone in combating the potentially life-threatening consequences of influenza virus infection. The newly developed drug, named UH15-38, demonstrates a unique ability to strike a delicate balance between suppressing excessive inflammation and

Paxlovid: A Vital Tool in Preventing Severe COVID-19, Yet Underutilized

Despite the availability of Paxlovid, a potent medication designed to prevent mild-to-moderate COVID-19 infections from escalating into more severe conditions, recent studies have revealed a significant under-prescription of this drug among eligible patients. With its efficacy demonstrated in clinical trials and its

How a Viral Peptide Drug Interacts with Liver Cells to Combat Hepatitis

Hepatitis B virus (HBV) and hepatitis D virus (HDV) infections pose significant threats to global health, contributing to liver-related ailments such as cirrhosis and hepatocellular carcinoma. Despite strides in treatment, these viruses continue to challenge medical researchers. However, a recent breakthrough published
Campaigns & Recent Studies

Connecticut Report Highlights Impact of Hospital Consolidations on Healthcare Costs and Services

A recent report from Connecticut’s Office of Health Strategy (OHS) has ignited a contentious debate regarding the effects of hospital consolidations on healthcare costs and the availability of essential services. The findings, released last week, indicate a correlation between hospital mergers and increased healthcare prices, prompting reactions from both legislators and industry stakeholders. The report, which focused on consolidations occurring between 2013 and 2019 and their impact on the years 2016 through 2021, highlighted several key observations. According to the OHS, hospitals affected by consolidation experienced accelerated growth in healthcare prices and a rise in the utilization of high-profit healthcare services during the study period. Senator Matt Lesser, co-chair of the
Diet & Nutrition

Food SENSE offers new ways of assessing and tackling malnutrition in Uganda.

CGIAR’s Sustainable Animal Productivity and Livelihoods, Nutrition and Gender inclusion Initiative (SAPLING) has developed a tool for assessing, identifying and responding to food and nutrition security problems in developing countries. The Food Security, Environments and Nutrition: Structured Evidence (FoodSENSE), is a decision support process developed by SAPLING researchers to aid decision makers in identifying barriers to improved food security and nutrition, and then to structure dialogue for prioritization of appropriate solutions for target demographic groups. The tool provides site-specific information on foods consumed, where they are sourced and the nutritional outcomes. It is also used to evaluate food systems and environments, including markets, value chains and socio-cultural

What Are The Signs That Iron Pills Are Working?

The signs that iron pills are working vary from person to person. Some people may notice an improvement in energy and other anemia symptoms. People without noticeable anemia symptoms may see little change. People often begin responding to iron pills within 2 weeks. A doctor can monitor if supplementation is working by

The “Medical Bypass”: New Drugs to Strike Obesity

The FDA has granted Mounjaro, drug that showed comparable potential to gastric bypass surgery, a Fast Track designation to treat obesity. In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. In
Country Reports

Egypt to Boost Health and Education Spending in Next Fiscal Year

In a bid to enhance public services and realize the objectives set forth in Egypt’s Vision 2030, the country's Finance Minister, Mohamed Maait, announced plans to significantly increase allocations for the health and education sectors in the upcoming general budget. According to Maait, Egypt is poised to allocate 495.6 billion pounds ($10.4 billion) to the health sector in the next fiscal year, marking a substantial 24.9 percent annual growth compared to the current fiscal period. This move underscores the nation’s commitment to improving medical services for its citizens, aligning with the overarching goals outlined in Egypt’s long-term development strategy, Vision 2030. Additionally, allocations for the education sector are set to receive a considerable boost, reaching 858.3 billion

Arab Health anticipates 3,000 companies from 70 countries for its next edition in January

The 2023 edition of Arab Health will return to the Dubai World Trade Centre from 30th January – 2nd February under the show's theme, 'Innovation and Sustainability in Healthcare', the organizers said. Exhibitor companies are also anticipated to rise, increasing from 2,828 to over 3,000 from 70 countries, according to Informa Markets. Arab Health has underscored its position as the epicenter of healthcare trade and reaffirmed its support for global businesses and governments by securing AED2.8 billion worth of healthcare industry-related contracts, according to a GRS Explore Exhibitor Survey during the 2022 edition, which was held in Dubai in January. The exhibition plays an integral role in supporting UAE Government initiatives such as ‘Make it in the Emirates’, a platform for developing



InnoHEALTH 2023


Medical Expo Lucknow 2023

South Africa

International Conference on Medical & Health Science 2023

United States of America

Practical AI for Drug Discovery & Preclinical Development Summit 2024

United States of America

Mayo Clinic Wound Symposium 2024

United Kingdom

Biomarkers UK 2024

United Arab Emirates

28th Asian Pacific Society of Cardiology Congress